HAL vs XGN · P/E 9.3, $19.05B cap vs rev $55.6M
Halliburton Company (HAL) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported XGN revenue for 2024-12-31 was $55.6M. Net income was -$15.1M. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. XGN currently screens at market cap $154.1M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. XGN currently screens at market cap $154.1M.
Not investment advice. Open the HAL and XGN stock pages for the full models.
Not investment advice.